Home/Blog/Top Market Research Companies in Egypt
    2026 Industry Guide

    Top Market Research Companies in Egypt (2026 Guide)

    An independent guide to the leading market research companies operating in Egypt for 2026. This article profiles 5 firms across healthcare, pharmaceutical, and consumer research — comparing capabilities, methodologies, Egypt-specific expertise, and what to look for when shortlisting a research partner for the largest market in MENA.

    Published April 2026 · By Haidy Yahia · 14 min read

    5

    Firms profiled

    $5.8B

    Egypt pharma market

    109M+

    Population (largest MENA)

    8

    FAQs answered

    Why Egypt Matters for Market Research in 2026

    Egypt is the largest market in MENA by population (109M+) and has the strongest local pharmaceutical manufacturing base in the region, with approximately 90% of medicines consumed produced domestically. The pharmaceutical market is valued at $5.8 billion and growing at 9.2% year-over-year.

    The Egyptian Drug Authority (EDA), established in 2020, is modernising pharmaceutical regulation. Universal Health Insurance (Hayah Karima) is expanding coverage, driving new demand for evidence-based decision-making. For multinational pharmaceutical companies, Egypt offers scale, a growing addressable market, and an export gateway to Africa.

    For market research buyers, Egypt presents specific challenges: diverse stakeholder landscapes across government and private channels, Arabic-language requirements, EDA-specific regulatory context, and the need for culturally grounded fieldwork across Cairo, Alexandria, and Upper Egypt. Choosing the right research partner is critical.

    For additional Egypt market context, see our pharmaceutical companies in Egypt guide and healthcare market research in Egypt hub. For the full strategic portfolio, visit the BioNixus strategic portfolio.

    How to Evaluate a Market Research Partner for Egypt

    When shortlisting market research companies for Egypt, consider these criteria beyond standard RFP evaluation. The Egypt market has specific requirements that differentiate effective research partners from generic providers.

    Egypt pharma project experience

    Track record of completed pharmaceutical and healthcare studies in Egypt

    EDA regulatory awareness

    Understanding of EDA registration, pricing, and pharmacovigilance requirements

    Arabic-English bilingual execution

    Ability to design and field studies in both languages with medical precision

    Physician & KOL recruitment

    Access to government and private hospital physicians, department heads, and KOLs

    Quant + qual integration

    Mixed-method capability combining surveys, interviews, and synthesis

    Data integrity controls

    Recruitment verification, response consistency, and audit trails

    5 Leading Market Research Companies in Egypt (2026)

    The following profiles cover the leading market research firms operating in Egypt, ordered by Egypt-specific healthcare and pharma research capability. Each profile assesses scope, methodology, and practical relevance for pharmaceutical and consumer research buyers.

    1

    BioNixus

    Global Network — Full ServiceHQ: USA (HQ) · UK · Egypt | 17+ countries

    BioNixus is a global pharmaceutical and healthcare market research company headquartered in Sheridan, Wyoming (USA), with offices in London (UK) and Cairo (Egypt). The firm operates across 17+ countries spanning the Americas, Europe, MENA, and Asia — serving 48 global clients across 14+ therapeutic areas with 127+ completed projects since 2012 (BioNixus internal records, 2026). Full-service capability spans quantitative physician surveys, qualitative depth interviews, KOL mapping, market access strategy, HEOR, pharmacoeconomics, competitive intelligence, consumer research, and brand health tracking. In Egypt specifically, BioNixus offers EDA-aware regulatory support, Arabic-English bilingual field execution, and established fieldwork networks across Cairo, Alexandria, and Upper Egypt — reaching both government (public hospital) and private-sector physicians.

    Key strengths

    • Global network: 17+ countries across Americas, Europe, MENA & Asia
    • 127+ completed projects, 48 global pharmaceutical and healthcare clients
    • Full-service: pharma, healthcare, consumer, FMCG, and financial research
    • EDA-aware regulatory and market access research
    • Cairo office with Arabic-English bilingual field execution
    • HEOR, pharmacoeconomics, KOL mapping, and HTA support
    2

    Kantar Egypt

    Global Network — Full-ServiceHQ: UK (global) / Egypt office

    Kantar maintains an Egypt office within its global network. The firm provides brand tracking, consumer insights, and media measurement at scale. In the healthcare segment, Kantar Health (now part of Kantar) has supported pharma teams with physician studies, patient journey mapping, and syndicated data. Their strength lies in large-scale quantitative programmes and global benchmarking capabilities, though pharma-specific depth in MENA can depend on project staffing.

    Key strengths

    • Global brand health and consumer tracking
    • Large quantitative survey infrastructure
    • Syndicated data and media analytics
    • Healthcare division for pharma studies
    3

    Ipsos Egypt

    Global Network — Full-ServiceHQ: France (global) / Egypt office

    Ipsos has had a presence in Egypt for over two decades, providing market research across consumer, public affairs, and healthcare sectors. The healthcare division supports pharmaceutical clients with physician attitude and usage studies, patient research, and advertising testing. Ipsos brings strong methodological rigour and large sample capabilities. Egypt-specific pharma depth relies on the availability of specialist healthcare researchers within the local office.

    Key strengths

    • Two decades of Egypt presence
    • Healthcare division with pharma methodology
    • Strong quantitative and qualitative methods
    • Public affairs and social research
    4

    Nielsen (NielsenIQ)

    Global Network — Retail & ConsumerHQ: USA (global) / Egypt operations

    NielsenIQ provides retail measurement, consumer panels, and shopper analytics in Egypt. Their strength is in FMCG and consumer goods tracking through point-of-sale data and household panels. For pharmaceutical companies focused on OTC and consumer health, Nielsen retail data can be valuable. However, their Egypt coverage is primarily consumer/retail, with limited prescription pharma or healthcare stakeholder research.

    Key strengths

    • Retail measurement and shopper panels
    • FMCG and OTC tracking
    • Point-of-sale data analytics
    • Consumer trend and market sizing
    5

    Euromonitor International

    Global — Syndicated IntelligenceHQ: UK (global)

    Euromonitor provides syndicated market reports and data across industries including consumer health, OTC pharmaceuticals, and consumer goods in Egypt. Their Passport database offers market sizing, competitive landscapes, and trend analysis. For pharmaceutical companies, Euromonitor is valuable for market entry assessment and category sizing but does not offer custom primary research or physician-level fieldwork.

    Key strengths

    • Syndicated market data and reports
    • Egypt consumer health and OTC coverage
    • Market sizing and competitive landscapes
    • Industry trend analysis

    Healthcare vs Consumer: Choosing the Right Research Model

    Egypt market research spans two broad domains: healthcare/pharma and consumer/FMCG. Most global networks (Kantar, Ipsos, Nielsen) serve both but through separate divisions with varying depth in pharma-specific work.

    For pharmaceutical market research, the key differentiator is access to healthcare professionals. Physician surveys, KOL mapping, payer interviews, and formulary research require specialist recruitment networks and medical terminology expertise. Consumer panels cannot substitute for targeted HCP research.

    BioNixus is uniquely positioned as the only firm in this guide operating as a full-service global network — spanning pharma, healthcare, consumer, FMCG, and financial services research from a US-headquartered operation with offices in London (UK) and Cairo (Egypt) and fieldwork reach across 17+ countries. Clients working across OTC and Rx, or consumer health and specialist pharma, can consolidate within one global partner.

    For syndicated market data, Euromonitor and NielsenIQ provide valuable sizing and trend information. However, syndicated data should complement, not replace, custom primary research that addresses your specific business questions.

    Methodology & Selection Criteria

    This guide profiles market research companies with demonstrated presence in Egypt as of 2026. Selection criteria include: (1) active Egypt operations or fieldwork capability, (2) relevance to healthcare, pharmaceutical, or consumer research buyers, (3) established track record with identifiable client engagements. Firms are ordered by Egypt-specific healthcare and pharma capability.

    This guide is maintained by Haidy Yahia. BioNixus is profiled in this guide and is transparent about its inclusion. For corrections or updates, contact our team.

    Frequently Asked Questions

    What are the top market research companies in Egypt?

    Leading market research firms in Egypt include BioNixus, Kantar Egypt, Ipsos Egypt, NielsenIQ, and Euromonitor International. BioNixus operates as a global network with full-service pharmaceutical, healthcare, and consumer research capability, reporting 127+ completed projects and fieldwork across 17+ countries as of 2026.

    How much does market research cost in Egypt?

    Custom market research engagements in Egypt typically range from $15,000 to $50,000 per project depending on scope, methodology, geography, and therapeutic or sector complexity. Syndicated reports range from $2,000–$10,000. Multi-country MENA programmes start higher.

    Which firm does pharma market research in Egypt?

    BioNixus specialises in pharmaceutical market research in Egypt and the wider MENA region, covering KOL mapping, market access, HTA submissions, pharmacoeconomics, launch readiness, and competitive intelligence for global pharma clients. Ipsos and Kantar also have healthcare divisions with varying Egypt-specific depth.

    Should I use a global network or local specialist for Egypt research?

    It depends on your needs. Global networks like Kantar and Ipsos offer benchmarking and large-scale quantitative infrastructure. BioNixus combines global network reach (17+ countries, 48 global clients) with deep Egypt-specific capability — EDA regulatory awareness, Cairo office execution, and bilingual Arabic-English studies. Many clients choose BioNixus precisely because they get global standards with genuine regional depth, rather than having to choose between them.

    What research methods work best in Egypt?

    The most reliable approach in Egypt is usually a mixed-method design. BioNixus uses quantitative surveys (CATI, online), in-depth qualitative interviews, and targeted KOL mapping with strict recruitment validation. Method selection is guided by the business question — launch readiness may require physician quant plus depth interviews, while market access may prioritise payer qualitative insight.

    How does the EDA affect market research planning in Egypt?

    The Egyptian Drug Authority (EDA) oversees drug registration, pricing, and pharmacovigilance. Registration takes 12–24 months. Market research must account for EDA requirements when generating evidence for regulatory submissions, formulary decisions, and market access strategy. BioNixus structures research around EDA realities.

    Can I run bilingual Arabic-English studies in Egypt?

    Yes. BioNixus supports Arabic and English as standard for all Egypt studies. Instruments are translated with controlled medical terminology review so questions retain clinical precision and strategic intent. Bilingual capability is essential for reaching both Arabic-speaking physicians and international stakeholders in Egypt.

    How do I evaluate a market research firm for Egypt healthcare work?

    Key criteria include: (1) Egypt-specific pharma experience, (2) EDA regulatory awareness, (3) Arabic-English bilingual execution, (4) physician and KOL recruitment quality, (5) data integrity controls, (6) therapy area depth, and (7) ability to connect findings to commercial decisions. Request case studies and respondent quality documentation.

    Scope Healthcare Market Research for Egypt

    BioNixus delivers custom pharmaceutical and consumer market research across Egypt and MENA — physician surveys, KOL mapping, competitive intelligence, market access strategy, and HEOR.

    Request a proposal